|
|
|
Audits
of FDA-regulated Medical Devices
Alpha Quality Assurance provides the medical
device industry with a full range of regulatory rule assessment and
quality system consulting, including audits for FDA and ISO
requirements. Our services include mock FDA inspections, quality system and
risk management system analysis, auditing, implementation and
training, premarket regulatory support, dispute resolution and many
other services.
Alpha
Quality Assurance services include:
QUALITY
SYSTEM REQUIREMENTS ADVISOR
-
Conform
and comply with the FDA's Quality System Regulations (QSR, 21
CFR 820) -Management Controls, Design Controls, Production and
Process Controls, Document Controls, Sterilization, Validation,
Packaging and Labeling requirements
-
Conform
and comply with ISO 13485:
2003 Medical Devices - Quality Management Systems ISO 14971
Risk Management 21 CFR 809 in vitro diagnostic product labeling
AUDIT
CAPABILIITES
-
Comprehensive
vendor, facility, and documentation quality audits
-
Independent
QS Regulation and Good Manufacturing Practice (GMP) audits
-
Simulated
pre-approval inspections
-
Combined
QS Regulation / ISO 9000:2000 / ISO 13485 pre-certification
audits
-
Design
control audits
-
Internal
audit training
-
CAPA
audits
-
Audit
and assist with medical device Quality System Regulation (FDA's
21 CFR 820) and ISO 13485 quality management systems
-
Assess
conformance to Good Clinical Practices (GCP)
-
Assess
conformance to Good Laboratory Practices (GLP)
REGULATORY
AFFAIRS
-
FDA
inspections and trends
-
Respond
to FDA 483 (Inspection Observations) and Warning Letters,
Corrections and Removable 21 CFR 806
-
Direct
corporate response to recalls 21 CFR 7, Medical Device
Reporting 21 CFR 803 (Adverse Events)
-
Current
US and EU Regulatory Requirements
-
Analytical
Equipment Qualification, Calibration, Documentation &
Maintenance
-
Validation
of Computerized Production and Lab Systems
-
Handling
OOS/OOT Results CGMPs for the Laboratory
-
Compliant
laboratory recordkeeping
-
Risk-based
vs. science-based approach
-
21
CFR Part 11 and the latest FDA guidance
|
|